Skip to main content

Table 1 The primary antibodies

From: EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features

Antibodies

Clone

Manufacturer

Dilution

ER

6F11

Ventana, Tucson, AZ, USA

Ready to use

PR

AB-52

Santa Cruz Biotechnology, Dallas, Texas, USA

1:100

HER2

Polyclonal

Sigma-Aldrich Shanghai Trading Co Ltd Shanghai, China

Ready to use

Ki67

MIB-1

DAKO, Denmark

Ready to use

CK5/6

D5/16B4

DAKO, Denmark

1:50

p63

4A4

Fuzhou Maixin, Biology, Fouzhou, China

Ready to use

CK14

LL002

Fuzhou Maixin, Biology, Fouzhou, China

Ready to use

EGFR

Polyclonal

Santa Cruz Biotechnology, Dallas, Texas, USA

1:100

EZH2

D2C9

Cell signaling Technology, Inc., Danvers, MA, USA

1:100

H3K27me3

C36B11

Cell Signaling Technology, Inc., Danvers, MA, USA

1:500